Invivyd, Inc. — Director's Dealing 2021

Aug 6, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2021-08-05

Reporting Person: Shah Anand (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$12.80	2031-06-29	Common Stock (125380)		Direct

Footnotes

F1: One quarter (1/4) of the options shall vest on June 30, 2022, and thereafter, the remainder of the options shall vest in 36 equal monthly installments on the 30th day of each month, subject to the Reporting Person's continuous service on each vesting date.